Baird Venture Partners (BVP), the U.S.-based venture capital fund of Baird Private Equity, announced today that its portfolio company Accuri Cytometers (Accuri) has signed a definitive agreement to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results